Proteomics International Laboratories (ASX:PIQ)
ASX announcement history & article coverage
Transparent by design.
Announcments by Proteomics International Laboratories (ASX:PIQ) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Application for quotation of securities - PIQ
US patent secured for PromarkerEndo
Proteomics International secures US patent for PromarkerEndo endometriosis diagnostic test
Notification of cessation of securities - PIQ
Response to ASX Price Query
Proteomics International denies undisclosed info amid unusual trading, confirms ASX compliance
Change of Registered Office Address
Application for Quotation of Securities - PIQ
Response to ASX Price Query
Proteomics International denies undisclosed info amid share price drop, cites recent strategic updates
Notification of Expiry of Listed Options - PIQO
Quarterly Activities/Appendix 4C Cash Flow Report
Proteomics International completes strategic review, restructures, reports $2.6M operating cash outflow and leadership changes
Proteomics Strategic Plan
Proteomics International advances commercial rollout of validated diagnostic tests with distributor model and reimbursement focus
Final Director's Interest Notice
Restructure, Executive Appointment and Board Update
Proteomics International restructures with 25% job cuts, appoints new CFO, and announces board retirement
